In the pharmaceutical field, applied nanoscience has emerged as a revolutionary frontier, offering unprecedented opportunities for drug delivery, diagnostics, and therapeutic interventions. Nanotechnology enables the manipulation of materials at the nanoscale, allowing for the design and fabrication of drug delivery systems with enhanced precision and efficacy. Nano-sized carriers, such as liposomes and nanoparticles, can encapsulate therapeutic agents, protecting them from degradation and facilitating targeted delivery to specific cells or tissues.
This precise drug targeting minimizes side effects and improves overall treatment outcomes. Additionally, nanoscale materials have proven invaluable in diagnostic applications, facilitating early disease detection through highly sensitive imaging techniques. The intersection of nanoscience and pharmaceuticals holds great promise for advancing personalized medicine, optimizing drug formulations, and addressing challenges in bioavailability. As researchers continue to explore and harness the potential of applied nanoscience, the pharmaceutical landscape stands poised for transformative advancements that can significantly impact patient care and treatment modalities.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico